8-K ·Filed Aug 31, 2026

HLF

HERBALIFE LTD.
BEARISH
Impact 5/10
Horizonweeks Processed1mo ago SEC0001213900-26-095328
8-K context-dependent: Items 5.02
Actionable Insight ▼ Bearish

Monitor for the naming of a successor and any additional details on the departure (resignation vs. termination). Look for a separate press release or subsequent 8-K providing clarity. Leadership uncertainty at a $1.3B company with a history of negative stock reactions to prior filings reinforces caution.

DirectionBearish
Confidencemedium
Horizonweeks
Latest settled — T+20d
HLF ▲ +13.19% at T+20d
SHORT call ✗ call lost -13.19% · α vs SPY -13.38% · entry $10.99 → $12.44
Next anchor: T+60d in 7w
Latest observation: T+22 -17.44% FF3 residual α
Entry anchored
Aug 31, 06:50 AM ET
via 1-min bar
T+1d
+4.82%
call -4.82% · α -5.51%
$11.52
settled 5w ago
T+5d
+13.10%
call -13.10% · α -13.24%
$12.43
settled 25d ago
T+20d
+13.19%
call -13.19% · α -13.38%
$12.44
settled 4d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

Herbalife Ltd. announced that CEO Stephan Gratziani will transition out of his role effective October 31, 2026. No reason (retirement, resignation, or termination) is specified, and no successor has been named. The lack of detail and absence of an immediate replacement creates leadership uncertainty for a company with a market cap of $1.3B.

Key Facts

  • CEO Stephan Gratziani to depart effective October 31, 2026
  • No reason given for departure
  • No replacement named as of the filing date
  • Company market cap ~$1.3B

Financial Impact

No financial figures provided in the filing; the event increases leadership risk.

Risk Factors

  • Leadership vacuum with no named replacement creates execution risk
  • Potential for further C-suite departures or organizational instability
  • Vague departure language ('transition') may signal internal discord or a forced exit

Market Snapshot

Exchange
NYSE
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-095328
Document: 0001213900-26-095328-index-headers.html0001213900-26-095328
Document: 0001213900-26-095328-index.html0001213900-26-095328
Document: 0001213900-26-095328.txt0001213900-26-095328
6 reports for HLF
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+5▲ +5.75%May 21, 2026
Filters
Rows
Reports for HLF — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
8-K
BEARISH ★ 5/10
$10.99 $12.44▼ −13.19%▼ −13.38%$12.56 (−14.29%)
May 21, 2026
19w ago
Insider Cluster
BEARISH ★ 5/10
$12.69 $12.20▲ +3.90%▲ +4.23%$12.56 (+1.02%)
May 6, 2026
21w ago
8-K
BULLISH ★ 7/10
$14.49 $11.39▼ −21.39%▼ −24.53%$12.56 (−13.32%)
May 1, 2026
22w ago
8-K
NEUTRAL ★ 5/10
$15.82 $11.90▼ −24.78%▼ −30.42%$12.56 (−20.61%)
Apr 14, 2026
24w ago
8-K
BULLISH ★ 8/10
$16.67 $13.51▼ −18.96%▼ −25.25%$12.56 (−24.66%)
Mar 17, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$15.12 $16.17▲ +6.94%▲ +0.90%$12.56 (−16.93%)
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (56h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access